Compare Abeona Therapeutics Inc (ABEO) vs LTC Properties Inc (LTC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs LTC Properties Inc — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while LTC Properties Inc trades at $39.24 (market cap $2.01B). The key difference: LTC Properties Inc is far larger — about 5.4× Abeona Therapeutics Inc's market cap, and LTC Properties Inc pays a 5.81% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | LTC | |
|---|---|---|
Market Cap | $373.32M | $2.01B |
Sector | Health | Real Estate |
52-Week High | $7.23 | $40.36 |
52-Week Low | $4.17 | $33.98 |
Enterprise Value | $228.22M | $2.86B |
Dividend Yield | — | 5.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
LTC Properties trades at $39.23, down 0.13% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 EPS of $0.69, missing expectations of $0.72, but revenue grew to $263M in 2025. Analyst consensus is mixed with 27% buy ratings, while recent news highlights dividend declarations and a $54M SHOP acquisition, reinforcing its focus on senior housing investments.
Outlook remains supported by demographic trends in senior housing, though earnings misses and high debt levels pose risks. The stock offers a monthly dividend, but investors face headwinds from execution challenges in shifting to SHOP strategy and interest rate sensitivity due to substantial leverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →
